<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>Lukaska Strategy &#38; Design - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/407754.xml</link>
<description>Lukaska Strategy &#38; Design - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>New Promotion Launched: Get 1 Free Pack of Feline Leukemia and Feline Immunodeficiency Virus Treatment Aid from IMULAN</title>
     <link>http://www.prweb.com/releases/feline-leukemia/felv-fiv/prweb908854.htm</link><description>   <![CDATA[ <P>Save on Lymphocyte T-Cell Immunomodulator (LTCI) from IMULAN BioTherapeutics, the first and only conditionally approved treatment aid in the United States for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV or Feline AIDS) infections. (PRWeb May 6, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/feline-leukemia/felv-fiv/prweb908854.htm">http://www.prweb.com/releases/feline-leukemia/felv-fiv/prweb908854.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/feline-leukemia/felv-fiv/prweb908854.htm</guid>
        </item>
</channel>
</rss>